TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2026

Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases.

Monica F Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.